Dow Chemical is hoping to push production of its Carbowax Sentry brand of polyethylene glycol ingredients up by a third over 2006/2007 levels by the end of the year, and put the production problems of recent months behind it.
AkzoNobel has been awarded a good manufacturing practice (GMP) certificate for Sanal (sodium chloride) salt manufactured at its plant in Mariager, Denmark.
Novozymes Biopolymer’s novel hyaluronic acid (HA) HyaCare has been named winner of this year’s gold innovation award at the CPhI worldwide conference in Frankfurt, Germany.
Pfizer is shifting its research focus to those diseases where its sees the potential for the biggest treatment improvements and profits, while dropping eight disease areas including cholesterol.
IPEC China must become a “harmonisation bridge between China and other countries,” according to Colorcon’s Nevin Cheng who was recently elected chairman of the new organisation.
Formatech hopes its new formulation method, which solubilises compounds in micelles consisting of fatty acids or alcohols, will improve both the safety and bioavailability of pharmaceutical products.
Sandoz Canada, a unit of Novartis’ generics arm, has opened a second manufacturing plant at its site in Boucherville, Quebec, boosting local production capacity 66 per cent.
Indian pharmaceutical firm Alembic is seeking to expand its presence in the lucrative US and European drug markets through an expanded partnering programme.
US fine and industrial chemicals specialist Aceto says that its expansion on the global stage, particularly in Europe and Asia, is starting to pay financial dividends.
Drug delivery specialist BioAlliance Pharma says that its decision to focus on the oncology and infectious disease markets helped it reduce its half-year 2008 losses.
UK and Swedish researchers have developed a system that eliminates the need for antibiotics and resistance genes in the engineering of biopharmaceutical products, making the process both safer and less costly.
UCB is moving forward with efforts to focus on CNS disorders and immunology and plans to cut around 2,000 jobs as part of its SHAPE restructuring program.
Contract services firm Marksans Pharmaceutical says that the RPS 1bn (€15.4m) acquisition of UK generics group Relonchem will expand its distribution network and build its presence in the European market.
in-PharmaTechnologist.com’s periodic round-up of employment developments in the pharmaceutical manufacturing industry includes news on Abbott, Pfizer, Gilead and Clarcor.
FDA officials have impounded nearly $24m (€15.4m) worth of guaifenesin-containing timed-release (TR) cough and cold medicines made by US specialty drugmaker KV Pharmaceuticals.
in-PharmaTechnologist.com's round-up of developments in the pharmaceutical manufacturing space features news of a fire at MY Healthcare, Helsinn's FDA approval and a safety award for Wyeth.
Roche’s proposed $44bn acquisition of Genentech is facing some opposition with Wall Street saying the offer undervalues the company, disquiet among the biotech’s employees and shareholders suing the Swiss giant.
The pace of change at GlaxoSmithKline (GSK) is showing no sign of slowing, with new CEO Andrew Witty unveiling the company’s new strategic direction with the release of second quarter results.
In an ironic twist, researchers have shown that the tobacco plant, the cause of millions of cases of cancer, can be harnessed to produce personalised cancer vaccines.
A new excipient could help drugmakers improve the delivery profiles
of active pharmaceutical ingredients (API), according to US
developer Eastman Chemical.
The new AccuSpray spray gun can reduce the amount of magnesium
stearate that pharmaceutical firms require during drug manufacture,
according to developer Oystar Manesty.
Lonza is to co-develop and manufacture Novartis' biological pipeline as part of a long term strategic partnership that has been struck between the companies.
Sangamo Biosciences and Sigma-Aldrich have licensed their zinc
finger nuclease (ZFN) technology to Roche to enable the pharma
giant to develop cell lines and transgenic animals.
A new Master Cell Bank (MCB) capable of producing pure cell culture
for the manufacture of the anti-biofilm enzyme DispersinB
represents a significant breakthrough, according to developer Kane
Biotech.
GlaxoSmithKline (GSK) has sold four of its off-patent drug products
to a South African drugmaker for £170m ($336m), describing the move
as part of an ongoing effort to simplify its manufacturing
operations.
New Mexico-headquartered drugmaker CytoDyn has begun the good
manufacturing practice (GMP) standard production of the
developmental candidate anti-HIV monoclonal antibody Cytolin
(lymphocyte function-associated antigen-1).
A deal to sell Pfizer's active pharmaceutical ingredient manufacturing (API) plant in County Cork, Ireland, has fallen through according to a statement by the US drug giant, placing over 180 production jobs under threat.
UK-based Sinclair Pharmaceuticals has entered into a manufacturing
and distribution agreement with Wockhardt, an Indian pharmaceutical
and biotech company.
in-PharmaTechnologist.com's periodic round-up of developments in
the field of pharmaceutical facilities includes news of two
environmental fines, MHRA plant approval and a strike at Teva.
UK drug major GlaxoSmithKline is examining operations at its active
pharmaceutical ingredient (API) manufacturing plant in Montrose,
Scotland, with an eye to potential job cuts.
Slovenian drugmaker Krka has paid just under $1.6m (€1m) for 7.5
per cent stakes in two Chinese drug and chemicals firms, namely
Zhejiang Menovo Pharmaceuticals and Anhui Menovo Pharmaceuticals.
Nventa Biopharmaceuticals hopes that the enhanced durability of its
new Poly IC-Poly arginine (Poly-ICR) adjuvant will help it capture
a significant share of the therapeutic and prophylactic vaccine
markets.
BASF's drug excipient manufacturing site in Geismar, Louisiana in
the USA has been accredited under the US Pharmacopoeia's (USP)
voluntary certification scheme.
The PER.C6 cell culture-based antibody production platform has
achieved a new record yield of 27 grams of IgG antibody per litre,
bettering the 15 gram per litre mark that was reported earlier in
the year.
Germany's Bayer hopes that its pilot-scale production facility in
Halle, Saxony-Anhalt will help establish its tobacco plant-based
expression system as leader of the lucrative protein manufacturing
sector.
Ineos Polyolefins hopes that its new Eltex MED low-density
polythene (LDPE) packaging line will provide pharmaceutical
manufacturing firms with a means of meeting the demands of long
term storage.
Japanese glass and chemical company Central Glass has found a swift
route into the contract manufacturing market for active
pharmaceutical ingredients (APIs) in Europe via the purchase of
Girindus' facility in Halle-Kuensebeck.
